Drug Information

Drug General Information
Drug ID
D0H9VQ
Former ID
DNC013243
Drug Name
L-norleucyl-L-prolinamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527857]
Structure
Download
2D MOL

3D MOL
Formula
C11H21N3O2
Canonical SMILES
CCCCC(C(=O)N1CCCC1C(=O)N)N
InChI
1S/C11H21N3O2/c1-2-3-5-8(12)11(16)14-7-4-6-9(14)10(13)15/h8-9H,2-7,12H2,1H3,(H2,13,15)/t8-,9-/m0/s1
InChIKey
AXARLGGBMIBEIZ-IUCAKERBSA-N
PubChem Compound ID
11615534
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [527857]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.